Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial
Titel:
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial
Auteur:
Harter, P. Marth, C. Mouret-Reynier, M.-A. Cropet, C. Lorusso, D. Guerra-Alía, E.M. Matsumoto, T. Vergote, I. Colombo, N. Mäenpää, J. Lebreton, C. de Gregorio, N. Mosconi, A.M. Rubio-Pérez, M.J. Bourgeois, H. Fasching, P.A. Cecere, S.C. Hardy-Bessard, A.-C. Denschlag, D. de Percin, S. Hanker, L. Favier, L. Bauerschlag, D. Desauw, C. Hillemanns, P. Largillier, R. Sehouli, J. Grenier, J. Pujade-Lauraine, E. Ray-Coquard, I.